Migratory thrombophlebitis during sandostatin (SMS 201-995, Sandoz) therapy for malignant carcinoid syndrome.
Nathanson
L
L
Winthrop-University Hospital, Mineola, NY 11501.
Sochet
A
A
Williams
M E
ME
D005260:Female; D006801:Humans; D008303:Malignant Carcinoid Syndrome / Q000188:drug therapy*; D008875:Middle Aged; D015282:Octreotide / Q000009:adverse effects* / Q000627:therapeutic use; D013924:Thrombophlebitis / Q000139:chemically induced*
D015282:Octreotide